Key Segment
By Product & Service
- Consumables
- Kits
- Reagents
- Instruments
- Software
- Services
- Others (Laboratory automation tools, Storage and logistics solutions specific to genomic workflows)
By Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray Technology
- Sanger Sequencing
- CRISPR/Cas Systems
- Others (Whole Genome Amplification (WGA), Nanopore sequencing, Digital PCR (dPCR)
By Application
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Reproductive & Prenatal Health
- Infectious Diseases
- Rare Diseases
- Others (Autoimmune diseases, Metabolic disorders, Personalized wellness, ETC.)
By Sample Type
- Blood Samples
- Tissue Samples
- Saliva Samples
- Urine Samples
- Others (Buccal swabs, Amniotic fluid, ETC.)
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Others (Contract research organizations (CROs), Direct-to-consumer (DTC) genetic testing companies)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: NGS technologies are foundational in enabling fast, scalable, and cost-effective DNA sequencing, supporting applications from genomics in oncology to infectious disease diagnostics.
Ans: Major precision genomic testing companies include Illumina, Thermo Fisher Scientific, Roche, QIAGEN, Guardant Health, and 10x Genomics, all driving precision healthcare innovation.
Ans: North America, particularly the U.S., dominates due to strong regulatory support, R&D spending, and clinical integration, followed by Europe and the rapidly growing Asia Pacific market.
Ans: Key drivers include increasing adoption of personalized medicine, rapid advancements in NGS technologies, and growing demand for genomic profiling in oncology and rare diseases.
Ans: The precision genomic testing market refers to the segment of healthcare focused on using genomic information to tailor diagnosis, treatment, and prevention strategies. It involves advanced DNA sequencing technologies and bioinformatics to support precision healthcare.
Get in touch
